Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 3 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 2 days agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...
Star Scientist’s Claim of ‘Reverse Aging’ Draws Hail of Criticism
The Wall Street Journal· 7 days agoHis lab there found that resveratrol appeared to prolong the lifespan of mice. Sinclair was one of...
Janssen adopts J&J name as part of global rebranding effort
Pharmaceutical Technology via Yahoo Finance· 3 days agoLast year, GSK rebranded as it demerged its consumer healthcare unit. Previously known as ...
Wall Street stocks end mostly down while dollar slides after Fed decision
AFP via Yahoo Finance· 3 days agoWall Street stocks finished a choppy session mostly lower while the dollar retreated Wednesday after...
These Are the Drugs America Is Running Short On
247wallst.com· 5 days agoDrug shortages in America are the result of supply line challenges, profit-based operations, and company closures.
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 3 days agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 4 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters· 3 days ago, opens new tab raised its full-year profit forecast on Wednesday on strong demand for its common...